Kelajakdagi narxning foydaga nisbati: carmellcosmetics.com (XAGE)

Carmell Therapeutics (XAGE) brendining ramzi va logotipi

Longevity Health Holdings (XAGE) kompaniyasining konsensus prognozli P/E ko'rsatkichi regenerativ shifokorlar va biologlar xodimlarining ish samaradorligi bilan bog'liq, 0.00 darajasi esa parametrning holatini ko'rsatadi. Biznes asosi plazma biomateriallari sohasidagi R&D ning me'yordagi rivojlanishiga tayanadi. Biroq, aktivlar birlashganidan keyin kosmetika komponentlarining qat'iy nazorati va brendni targ'ib qilish xarajatlari barqarorlikka to'sqinlik qilmoqda.

Carmell Therapeutics - XAGE Kapitalizatsiyaning kelajakdagi foydaga nisbati (davr: 11.03.2025 - 27.09.2025)

carmellcosmetics.com (XAGE) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahliliyoti:Carmell Therapeutics Corporation
Longevity Health Holdings brend mahsuloti

Forward P/E joriy kotirovkaning prognoz qilingan foyda miqdoriga nisbatini aks ettiradi, bu esa investorlarga kelajakdagi biznes o'sish sur'atlari uchun to'langan premiumni baholash imkonini beradi. GURU.Markets tizimi doirasida, emitentning kutilayotgan P/E ko'rsatkichi Longevity Health Holdings (XAGE) bozor qiymatini avtomatlashtirilgan oqsil sintezining samaradorligi bilan bog'lashga yordam beradi, bunda xodimlarning sonini oshirmasdan ishlab chiqarishni kengaytirish marjalarni optimallashtirishi kerak, bu ushbu grafikda aniq ko'rsatilgan.

Raqobatchilar tahlili

Kelajakdagi narxning foydaga nisbati HCA Holdings (HCA)|Tenet Healthcare - Narxning kelajakdagi foydaga nisbati|Fresenius Medical Care Corp - Prognoz qilingan narxning foydaga nisbati|SOLV: Narxning kelajakdagi foydaga nisbati|Encompass - Forvard P/E multiplikatori|UHS - Forvard P/E multiplikatori|DVA: Forvard P/E multiplikatori|RadNet Corp - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Option Care Health Inc|Forvard P/E multiplikatori surgerypartners.com|Forvard P/E multiplikatori PINC|Kapitalizatsiyaning prognoz qilingan foydaga nisbati National Vision Holdings, Inc.|Forvard P/E multiplikatori PGNY (Progyny Inc)|Ardent Health Corp (ARDT) - Prognoz qilingan narx-foyda nisbati|SEM: Prognoz qilingan narxning foydaga nisbati|ASTH - Forvard P/E multiplikatori|MD: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati USPH (US Physical Therapy)|Kelajakdagi narxning foydaga nisbati The Pennant Group, Inc.|ORGO - Forvard narx-foyda multiplikatori|Forvard P/E multiplikatori NUTX|Forvard P/E multiplikatori Auna (AUNA)|Forvard P/E multiplikatori SBC (sbc-holdings.com)|EOLS: Narxning kelajakdagi foydaga nisbati|Community Health Systems Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati The Beauty Health Company|MediWound Ltd (MDWD) - Kelajakdagi narxning foydaga nisbati|BTMD - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati The Joint|Prognoz qilingan narxning foydaga nisbati DocGo (DCGO)|P3 Health Partners, Inc. (PIII) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori Gain Therapeutics (GANX)|Forvard P/E multiplikatori EUDA (EUDA Health)|Kelajakdagi narx-foyda multiplikatori BMGL|CollPlant Ltd - Forvard P/E multiplikatori|Forvard narx-foyda multiplikatori Cuprina Holdings (Cayman) Ltd. (CUPR)|Concord Medical Corp (CCM) - Kelajakdagi narxning foydaga nisbati|ASHS - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati MEDIROM Healthcare Group|Forvard P/E multiplikatori avalon-globocare.com|Forvard P/E multiplikatori DHAI|Kapitalizatsiyaning prognoz qilingan foydaga nisbati NewGenIvf Group|Kelajakdagi narxning foydaga nisbati ATI Physical Therapy Inc. ATIP|CareMax Medical Group (CMAX) - Prognoz qilingan narx-foyda nisbati|KDLY - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori MODV (ModivCare Inc.)|Novo Integrated (NVOS) - Kelajakdagi narxning foydaga nisbati|SSY - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati IMAC Holdings Inc